To verify that macrophages confer enhanced protection in Lyz2-DP1−/− mice, we blocked macrophage infiltration into the infected brain by treating mice with CCR2-blocking (MC21 monoclonal antibody [mAb]) (27, 28) or control antibody 1 day before and 3 and 7 days after infection. The gene discussed is CCR2; the disease is infection.